Agilent Technologies, Inc. with ticker code (A) now have 16 analysts in total covering the stock. The consensus rating is pointing to ‘buy’. The range between the high target price and low target price is between 163 and 105 and has a mean target at $137.38. Given that the stocks previous close was at $113.29 this now indicates there is a potential upside of 21.3%. There is a 50 day moving average of $117.53 while the 200 day moving average is $130.76. The market capitalization for the company is 33.17B. The stock price for the company is currently is currently 113.38 USD
The potential market cap would be $40,227,534,525 based on the market consensus.
The company has a dividend yield of 2.35%. Other points of data to note are a P/E ratio of 29.68, revenue per share of 23.69 and a 8.79% return on assets.
Agilent Technologies, Inc. is engaged in providing application-focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. It operates in the life sciences, diagnostics and applied chemical markets. Its life sciences and applied markets business offers application-focused solutions that include instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products. Its diagnostics and genomics businesses are comprised of six areas of activity, providing active pharmaceutical ingredients for oligo-based therapeutics as well as solutions that include reagents, instruments, software, and consumables which enable customers in the clinical and life sciences research areas to interrogate samples at the cellular and molecular level. Its product categories include liquid chromatography systems and components and liquid chromatography mass spectrometry systems.
